Selected article for: "infected individual and novel pathogen"

Author: Yang Ge; Brian Kenneth McKay; Shengzhi Sun; Feng Zhang; Andreas Handel
Title: Assessing the impact of a symptom-based mass screening and testing intervention during a novel infectious disease outbreak: The case of COVID-19
  • Document date: 2020_2_23
  • ID: 4gaa14ly_5
    Snippet: The default is to ask individuals with symptoms to stay home and follow general precautionary 37 measures [8] . An alternative option is to implement MSTI, which requires testing anyone with 38 symptoms specific for the novel pathogen at a healthcare facility. individual is infected with the novel pathogen (probability ), we assume that they are correctly 49 identified and placed under isolation and treatment, where they have reduced transmission.....
    Document: The default is to ask individuals with symptoms to stay home and follow general precautionary 37 measures [8] . An alternative option is to implement MSTI, which requires testing anyone with 38 symptoms specific for the novel pathogen at a healthcare facility. individual is infected with the novel pathogen (probability ), we assume that they are correctly 49 identified and placed under isolation and treatment, where they have reduced transmission and 50 mortality risks, namely and . Importantly, if the health system is strained, those patients 51 arriving at the testing facility without being infected with the novel pathogen (probability 1 − ) 52 may become infected by another person in the testing facility. We denote this probability of 53 becoming infected with . Since these individuals test negative, we assume they will be sent 54 home and then have the same transmission and mortality risk as individuals asked to remain at 55 home. Thus, the total transmission potential for a person undergoing screening is = + 56

    Search related documents:
    Co phrase search for related documents
    • alternative option and home stay: 1
    • alternative option and mortality risk: 1
    • alternative option and novel pathogen: 1
    • health system and home stay: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • health system and mortality risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • health system and mortality transmission: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • health system and negative test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • health system and novel pathogen: 1, 2, 3, 4
    • health system and testing facility: 1, 2, 3
    • healthcare facility and home stay: 1
    • healthcare facility and mortality risk: 1, 2, 3, 4, 5, 6
    • healthcare facility and mortality transmission: 1
    • healthcare facility and mortality transmission risk: 1
    • healthcare facility and negative test: 1, 2
    • healthcare facility and testing facility: 1, 2, 3, 4
    • home stay and mortality risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • home stay and mortality transmission: 1, 2, 3, 4, 5, 6
    • home stay and negative test: 1, 2, 3, 4, 5
    • individual negative test and negative test: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13